CJC-1295
Hormonal signaling
Long-acting GHRH analog. GH and IGF-1 responses and pharmacokinetics in controlled research.
Not FDA-approved
Integrated Wellness · The science, in context
Understand the molecule. Question the claim.
Explore peptides and related molecules through mechanisms, published research and what we still don’t know. Clear science. No sales. No shortcuts.
A better research lens
A promising mechanism is the beginning of a question—not the end of one.
Cells & models
What might happen?
Human studies
What happens in people?
Clinical outcomes
Does it meaningfully help?
Regulatory context
For which product and use?
A more visual way to learn
Start with recovery, metabolism or longevity. Build your vocabulary, explore the biology and keep track of what you’ve read.
The research directory
10 of 35 molecules
Hormonal signaling
Long-acting GHRH analog. GH and IGF-1 responses and pharmacokinetics in controlled research.
Not FDA-approved
Hormonal signaling
Synthetic growth-hormone-releasing peptide (pralmorelin). Human endocrine responses and GH-stimulation testing.
Not FDA-approved
Hormonal signaling
Synthetic hexapeptide secretagogue. GH secretion and related endocrine feedback.
Not FDA-approved
Hormonal signaling
Synthetic hexapeptide secretagogue. Pituitary endocrine responses compared with ghrelin and GHRH.
Not FDA-approved
Muscle performance
Modified long-acting IGF-1 analog. Growth-factor signaling in cell culture and animal models.
Not FDA-approved
Hormonal signaling
Synthetic pentapeptide secretagogue. GH signaling and gastrointestinal motility research.
Not FDA-approved
Metabolic health
Mitochondrial-derived 16-amino-acid peptide. Metabolic stress, insulin sensitivity and skeletal-muscle signaling.
Not FDA-approved
Muscle performance
Pegylated MGF-related research construct. Muscle progenitor-cell and growth-factor biology.
Not FDA-approved
Hormonal signaling
GHRH (1–29) analog. Pituitary GH response and historical pediatric GH-deficiency research.
Historical FDA product · discontinued
Tissue repair
Thymosin-beta-4-related fragment label. Cell migration and tissue-repair hypotheses.
Not FDA-approved
Entries may appear in more than one category. Category placement describes research interest, not proven benefit. This is a curated selection, not a systematic review; source gaps are identified inside each profile.
Beyond the library
Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.
Continue to our existing activation & intake page.
Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.